Published in Am J Psychiatry on February 01, 1980
Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics. Eur Arch Psychiatry Neurol Sci (1988) 0.78
Reimmunization Against Diphtheria of Previously Immunized Children. Am J Public Health Nations Health (1942) 7.70
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry (1995) 7.19
National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry (1989) 6.63
Diphtheria Immunization with Fluid Toxoid and Alum-Precipitated Toxoid. Am J Public Health Nations Health (1942) 3.95
Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate. Am J Psychiatry (1983) 3.23
Skeletal disease in primary hyperparathyroidism. J Bone Miner Res (1989) 3.00
A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry (1982) 2.75
Comparative Speed of Response of Previously Immunized and Non-Immunized Children to Fluid and Alum-Precipitated Diphtheria Toxoid. Am J Public Health Nations Health (1943) 2.49
The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry (1990) 2.41
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A (2005) 2.38
Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry (1999) 2.32
Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A (2004) 2.19
Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 2.11
Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. Arch Gen Psychiatry (1999) 2.03
Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry (1996) 1.84
Clomipramine-induced mania in unipolar depression. Arch Gen Psychiatry (1979) 1.81
The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med (2000) 1.81
Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract (2001) 1.81
Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry (1993) 1.80
Diphtheria Studies: I-The Significance of the Schick Test in the Adult. Am J Public Health Nations Health (1934) 1.75
Diphtheria Immunization With Fluid Toxoid and Alum Precipitated Toxoid -Preliminary Report. Am J Public Health Nations Health (1939) 1.73
Depression in first-episode schizophrenia. Am J Psychiatry (1993) 1.71
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int (2010) 1.69
A review of child psychotherapy research since 1963. J Am Acad Child Adolesc Psychiatry (1991) 1.68
Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology (1997) 1.63
Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophr Res (1998) 1.63
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry (1982) 1.58
Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci (1996) 1.50
No cytogenetical abnormalities in a set of schizophrenic quadruplets. Biol Psychiatry (1997) 1.47
Semantic priming in schizophrenia: an examination of spreading activation using word pronunciation and multiple SOAs. J Abnorm Psychol (1996) 1.45
Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry (2010) 1.42
Preparing psychiatric residents for managed care. Values, proficiencies, curriculum, and implications for psychotherapy training. J Psychother Pract Res (1997) 1.41
Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med (1990) 1.39
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc Natl Acad Sci U S A (2000) 1.37
Consensus methods in practice guideline development: a review and description of a new method. Psychopharmacol Bull (1997) 1.37
Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry (1990) 1.35
GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex (1996) 1.31
The Expert Consensus Guideline Series. Treatment of behavioral emergencies. Postgrad Med (2001) 1.31
Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry (1982) 1.30
Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry (1993) 1.30
Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs (2001) 1.29
Leukocytosis during lithium treatment. Am J Psychiatry (1971) 1.27
A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry (1983) 1.26
Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res (1990) 1.25
Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Sci (1989) 1.25
Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry (1965) 1.24
The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med (2001) 1.24
Empirical validation of primary negative symptoms: independence from effects of medication and psychosis. Am J Psychiatry (1999) 1.21
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry (1997) 1.18
Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma. N Engl J Med (1980) 1.18
Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry (2007) 1.18
Colorectal cancer screening: video-reviewed flexible sigmoidoscopy by nurse endoscopists--a Canadian community-based perspective. Can J Gastroenterol (2001) 1.18
The Expert Consensus Guideline Series. Treatment of depression in women. Postgrad Med (2001) 1.16
Pertussis agglutinins in adults. Public Health Rep (1969) 1.16
Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet (1998) 1.16
Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines. J Psychiatr Pract (2001) 1.16
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication. Clin Pharmacol Ther (1985) 1.15
Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2008) 1.15
Prediction of imipramine antidepressant response by a one-day dextro-amphetamine trial. Am J Psychiatry (1978) 1.13
Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry (1969) 1.13
Antibody response to booster dose of diphtheria and tetanus toxoids: Reactions in institutionalized adults and non-institutionalized children and young adults. Public Health Rep (1963) 1.13
Stimulation by lithium of monoamine uptake in human platelets. Life Sci (1969) 1.11
PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry (1996) 1.11
Quantitative studies of norepinephrine uptake by synaptosomes. Biochem Pharmacol (1968) 1.11
Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A (1998) 1.11
DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles. Neurobiol Dis (2003) 1.10
A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. J Nerv Ment Dis (1987) 1.10
Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet (1968) 1.09
Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med (1976) 1.08
A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group. Am J Med (1999) 1.08
Confirmatory factor analysis of the WAIS-R in patients with schizophrenia. Schizophr Res (1998) 1.07
L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients. Biol Psychiatry (1970) 1.07
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 1.07
The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. Sleep (1991) 1.07
Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature (1977) 1.07
Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the National Osteoporosis Risk Assessment (NORA) study. Osteoporos Int (2007) 1.06
Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2007) 1.05
Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry (1992) 1.05
Beyond bone mineral density: can existing clinical risk assessment instruments identify women at increased risk of osteoporosis? J Intern Med (2004) 1.05
Hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes. Schizophr Bull (2000) 1.04
A clinical approach to diagnosis and management of Paget's disease of bone. J Bone Miner Res (2001) 1.04
Targeted treatment of depression-like symptoms in schizophrenia. Psychopharmacol Bull (1987) 1.03
The inheritance of affective disorders: a review of data and of hypotheses. Behav Genet (1976) 1.03
Seasonal affective disorder: prevalence varies with latitude and climate. Clin Neuropharmacol (1986) 1.03
Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia. Mol Psychiatry (2003) 1.03
Bisphosphonates and iritis. Lancet (1993) 1.03
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berl) (1980) 1.02
Lithium response in unipolar versus bipolar depression. Am J Psychiatry (1972) 1.01
Survivors of imprisonment in the Pacific theater during World War II. Am J Psychiatry (1987) 1.01
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00
The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry (1972) 1.00
Modulation of language processing in schizophrenia: effects of context and haloperidol on the event-related potential. Biol Psychiatry (1999) 1.00
Reduced level of plasma antioxidant uric acid in schizophrenia. Psychiatry Res (1998) 0.99
Age-related changes in sleep in depressed and normal subjects. Psychiatry Res (1981) 0.99
Treatment of depression in women: a summary of the expert consensus guidelines. J Psychiatr Pract (2001) 0.99
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry (1993) 0.99
L-tryptophan in affective disorders: indoleamine changes and differential clinical effects. Psychopharmacologia (1974) 0.98